Tirzepatide Mounjaro, a new Dual-Targeted Treatment for T2DM, was approved in May 2022 and recently approved for weight management
Among the most sustained efforts at reform is the Treat and Reduce Obesity Act, federal legislation which would allow Medicare to cover anti-obesity medications
We base each of our health plans on the unique needs of your body
Key Points: GI symptoms are the most common adverse effects, ranging from expected nausea and vomiting to gastroparesis and, rarely, functional obstruction Delayed gastric emptying has important airway implications and a cautious approach to airway management is warranted Biliary disease is one of the most clinically significant complications, particularly early in treatment and with rapid weight loss Pancreatitis is rare, and current evidence does not support a strong causal relationship EDKA and AKI are uncommon but important to recognize in the right context Conclusions: GLP-1 receptor agonists have transformed the management of diabetes and obesity, with clear benefits in weight loss, glycemic control, and cardiovascular outcomes
Known as a powerful copper peptide, its often praised for improving skin firmness, reducing fine lines, and supporting collagen production
The Springville location has a 2023 pharmacy violation ($750) and a 2025 pharmacy violation ($1,050)